Overview
Timothy Thomsen is a Palliative Medicine provider practicing medicine in Iowa City, Iowa.
His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
He is actively involved in clinical research, co-authoring 3 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
200 Hawkins Dr, Iowa City, IA 52242
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Iowa Stead Family Children's Hospital
Michelle Weckmann is a Palliative Medicine provider practicing medicine in Iowa City, Iowa. Her clinical expertise encompasses Seasonal Affective Disorder (SAD) and Schizoaffective Disorder. Dr. Weckmann is currently accepting new patients.
University Of Iowa Stead Family Children's Hospital
Mark Rostad is a Palliative Medicine provider practicing medicine in Iowa City, Iowa. He has been practicing medicine for over 10 years. His clinical expertise encompasses Liver Embolization and Bone Marrow Aspiration. Dr. Rostad is currently accepting new patients.
University Of Iowa Stead Family Children's Hospital
Abimbola Olayinka is a Palliative Medicine provider practicing medicine in Iowa City, Iowa. Her clinical expertise encompasses Glycogen Storage Disease Type 9, Glycogen Storage Disease Type 13, Glycogen Storage Disease Type 7, and Phosphoglycerate Kinase Deficiency. Dr. Olayinka is currently accepting new patients.
Frequently Asked Questions about Dr. Timothy A. Thomsen
How do I make an appointment with Dr. Timothy A. Thomsen?
You can book an appointment with Dr. Timothy A. Thomsen by calling their office at 319-356-3890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Timothy A. Thomsen a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Timothy A. Thomsen is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Timothy A. Thomsen specialize in?
While Dr. Timothy A. Thomsen is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Timothy A. Thomsen participate in research or clinical trials?
Yes. Dr. Timothy A. Thomsen has published 3 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Timothy A. Thomsen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Timothy A. Thomsen accept my insurance?
Dr. Timothy A. Thomsen accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 319-356-3890 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Thomsen isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.